je.st
news
European Commission Approves RELVAR ELLIPTA To Treat Asthma And COPD
2013-11-21 09:36:25| drugdiscoveryonline News Articles
RELVAR® ELLIPTA® has been given marketing authorization by the European Commission for the treatment of asthma and COPD.
Tags: european
commission
treat
european commission
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|